Structure and Cell Biology of Viral Infections
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "General Virology".
Deadline for manuscript submissions: closed (15 July 2022)
Special Issue Editor
Interests: infections diseases; vaccine; viral vectors; CAR-T cells; process development and manufacturing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
To cover the latest updates in the field of virology, we would like to invite you to submit your original research or review articles from fundamental structure and cell biology to advanced research translation as well as clinical study and commercial drug development. The interesting areas for the specific issue are 3D structural-based design together with cell-based technology for monoclonal antibody discovery, antiviral drugs, and vaccines to prevent viral infections and engineering viral vectors for gene and CAR-T cell therapy.
We would like to cover various viruses, such as (1) coronavirus as the cause of the COVID-19 pandemic and the urgent issues associated with it that need to be addressed; (2) HIV/SIV as the most advanced research field in antiviral therapy and vaccine development; (3) adenovirus and viral vectors for vaccine and gene delivery; (4) lentiviral vectors as major tools for CAR-T cells in oncology; (5) AAV as a major delivery tool for gene therapy in rare diseases; and (6) other viruses or emerging viruses which may have implications for basic knowledge or therapeutic development.
Dr. Hung V. Trinh
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Monoclonal antibody
- Antiviral drugs and vaccine
- Clinical and commercial drug
- Coronavirus
- HIV/SIV
- Adenovirus
- Lentiviral vectors
- Adeno-associated virus (AAV)
- Viral vectors for gene and CAR-T cell therapy
- Emerging viruses
